IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 193 filers reported holding IMMUNOGEN INC in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $277,779,228 | -17.0% | 17,503,417 | -1.3% | 13.22% | +2.9% |
| Q2 2023 | $334,572,969 | +982.8% | 17,730,417 | +120.4% | 12.84% | +857.6% |
| Q1 2023 | $30,897,473 | -27.0% | 8,046,217 | -5.7% | 1.34% | -22.5% |
| Q4 2022 | $42,322,772 | +3.6% | 8,532,817 | -0.2% | 1.73% | +9.2% |
| Q3 2022 | $40,860,000 | -0.7% | 8,548,145 | -6.5% | 1.58% | +0.9% |
| Q2 2022 | $41,135,000 | -6.2% | 9,141,045 | -0.8% | 1.57% | +14.7% |
| Q1 2022 | $43,877,000 | -28.4% | 9,217,945 | +11.6% | 1.37% | -1.7% |
| Q4 2021 | $61,277,000 | +30.9% | 8,258,345 | 0.0% | 1.39% | +70.5% |
| Q3 2021 | $46,825,000 | -20.0% | 8,258,345 | -7.0% | 0.82% | -5.7% |
| Q2 2021 | $58,525,000 | -25.4% | 8,880,945 | -8.3% | 0.87% | -21.6% |
| Q1 2021 | $78,473,000 | +15.6% | 9,688,066 | -8.0% | 1.10% | +34.4% |
| Q4 2020 | $67,907,000 | +80.0% | 10,528,179 | +0.5% | 0.82% | +18.8% |
| Q3 2020 | $37,720,000 | -31.7% | 10,477,879 | -12.7% | 0.69% | -32.2% |
| Q2 2020 | $55,232,000 | -3.2% | 12,006,979 | -28.2% | 1.02% | -36.2% |
| Q1 2020 | $57,063,000 | -23.6% | 16,733,879 | +14.3% | 1.60% | -10.5% |
| Q4 2019 | $74,737,000 | +111.3% | 14,639,960 | +0.2% | 1.79% | +51.0% |
| Q3 2019 | $35,372,000 | +16.8% | 14,616,560 | +4.7% | 1.18% | +38.2% |
| Q2 2019 | $30,282,000 | -14.5% | 13,954,794 | +6.8% | 0.86% | -17.3% |
| Q1 2019 | $35,403,000 | -32.2% | 13,063,767 | +20.0% | 1.04% | -50.7% |
| Q4 2018 | $52,246,000 | -55.2% | 10,884,607 | -11.6% | 2.10% | -41.4% |
| Q3 2018 | $116,567,000 | -2.7% | 12,309,035 | -0.1% | 3.59% | -11.9% |
| Q2 2018 | $119,834,000 | +17.4% | 12,315,942 | +26.9% | 4.07% | +3.3% |
| Q1 2018 | $102,070,000 | +46.0% | 9,702,482 | -11.0% | 3.94% | +29.7% |
| Q4 2017 | $69,914,000 | +13.4% | 10,906,962 | +35.3% | 3.04% | -0.1% |
| Q3 2017 | $61,670,000 | +66.4% | 8,061,497 | +54.7% | 3.04% | +34.8% |
| Q2 2017 | $37,063,000 | +140.3% | 5,212,736 | +30.8% | 2.26% | +125.4% |
| Q1 2017 | $15,421,000 | – | 3,984,734 | – | 1.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |